Arcosa Inc. logo

Arcosa Inc. (ACA)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
147. 06
+0.05
+0.034%
$
7.23B Market Cap
13.56 P/E Ratio
0.2% Div Yield
403,400 Volume
3.04 Eps
$ 147.01
Previous Close
Add Transaction
Day Range
146.87 147.32
Year Range
90.9 147.5
Want to track ACA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcosa, Inc. (ACA) Q1 2025 Earnings Call Transcript

Arcosa, Inc. (ACA) Q1 2025 Earnings Call Transcript

Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Officer Gail Peck - Chief Financial Officer Conference Call Participants Julio Romero - Sidoti & Company. Brent Thielman - D.A.

Seekingalpha | 1 year ago
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates

Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates

Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.

Zacks | 1 year ago
New Strong Sell Stocks for May 2nd

New Strong Sell Stocks for May 2nd

ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.

Zacks | 1 year ago
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business

CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.

Wsj | 1 year ago
Is the Options Market Predicting a Spike in Arcosa (ACA) Stock?

Is the Options Market Predicting a Spike in Arcosa (ACA) Stock?

Investors need to pay close attention to Arcosa (ACA) stock based on the movements in the options market lately.

Zacks | 1 year ago
New Strong Sell Stocks for April 7th

New Strong Sell Stocks for April 7th

ASTS, AMPY and ACA have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2025.

Zacks | 1 year ago
Arcosa Is Poised For A Rebound In 2025 (Rating Upgrade)

Arcosa Is Poised For A Rebound In 2025 (Rating Upgrade)

ACA's topline grew 14.4% YoY in Q4 2024, driven by strong pricing and recent acquisitions, despite a 14% decline in Transportation Products revenue. Expect continued growth in 2025, fueled by strong infrastructure demand, significant backlogs, and contributions from recent acquisitions like Stavola. ACA is optimizing its portfolio through strategic acquisitions and divestitures, aiming to reduce net leverage from 2.9x to its long-term target of 2-2.5x.

Seekingalpha | 1 year ago
Arcosa, Inc. (ACA) Q4 2024 Earnings Call Transcript

Arcosa, Inc. (ACA) Q4 2024 Earnings Call Transcript

Arcosa, Inc. (NYSE:ACA ) Q4 2024 Earnings Conference Call February 28, 2025 8:30 AM ET Company Participants Erin Drabek - Vice President of Investor Relations Antonio Carrillo - President and CEO Gail Peck - CFO Conference Call Participants Ian Zaffino - Oppenheimer Garik Shmois - Loop Capital Markets Operator Good morning ladies and gentlemen, and welcome to the Arcosa Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Britney, and I will be your conference call coordinator today.

Seekingalpha | 1 year ago
Arcosa (ACA) Lags Q4 Earnings and Revenue Estimates

Arcosa (ACA) Lags Q4 Earnings and Revenue Estimates

Arcosa (ACA) came out with quarterly earnings of $0.46 per share, missing the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.68 per share a year ago.

Zacks | 1 year ago
New Strong Sell Stocks for February 14th

New Strong Sell Stocks for February 14th

EADSY, CSX and ACA have been added to the Zacks Rank #5 (Strong Sell) List on February 14, 2025.

Zacks | 1 year ago
5 Building Products Stocks for Better Returns Despite the Industry Woes

5 Building Products Stocks for Better Returns Despite the Industry Woes

A focus on operational efficiencies and higher government spending raises hope for AWI, ACA, ROAD, FTDR and SWIM.

Zacks | 1 year ago
Arcosa, Inc. (ACA) Q3 2024 Earnings Call Transcript

Arcosa, Inc. (ACA) Q3 2024 Earnings Call Transcript

Arcosa, Inc. (NYSE:ACA ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Officer Gail Peck - Chief Financial Officer Conference Call Participants Trey Grooms - Stephens, Inc. Ian Zaffino - Oppenheimer & Co. Inc. Brent Thielman - D.A. Davidson & Co. Operator Good morning, ladies and gentlemen, and welcome to the Arcosa, Inc. Third Quarter 2024 Earnings Conference Call.

Seekingalpha | 1 year ago
Loading...
Load More